Signaturefd, LLC Aclaris Therapeutics, Inc. Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$6.56 - $10.95 $767 - $1,281	-117 Reduced 42.09%	161 $1,000
Q2 2023 Aug 01, 2023	SELL	$7.89 - $10.64 $157 - $212	-20 Reduced 6.71%	278 $2,000
Q1 2023 Apr 28, 2023	BUY	$7.07 - $17.95 $1,675 - $4,254	237 Added 388.52%	298 $2,000
Q4 2022 Jan 27, 2023	SELL	$14.33 - $18.37 $573 - $734	-40 Reduced 39.6%	61 $0
Q3 2022 Nov 08, 2022	BUY	$13.07 - $18.22 $1,320 - $1,840	101 New	101 $2,000
Q2 2022 Aug 10, 2022	SELL	$10.16 - $17.08 $436 - $734	-43 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$9.74 - $17.92 $194 - $358	-20 Reduced 31.75%	43 $1,000
Q4 2021 Jan 25, 2022	BUY	$12.27 - $18.49 $773 - $1,164	63 New	63 $1,000

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.